Project Bioshield Update

If you are planning on joining the united states military anytime soon you will get to be the expirement for future drug tests for the military not only for the later use on the population but also for the future withholding
of medical records so that no future lawsuit can be sent against the people pushing such expirements.

Here is the artical I will try to get a hold of the bill number so people can have that as well but as far as I know right now it is called Project Bioshield Act of 2003

www.nti.org...

Falcon

Will this bill help regain already withheld medical records?
This might be really worth remembering.

Sec. 1107. - Notice of use of an investigational new drug or a drug unapproved for its applied use

Thanks.


[Edited on 9-9-2003 by ADVISOR]

�Project Chatter - U.S. Navy Human Drug Test Program�






www.blackvault.com...




www.blackvault.com...

April 18, 2005
The Defense Department has unveiled an international effort to develop a vaccine that would protect against the plague.

Defense officials announced the project Friday and said Pentagon scientists will collaborate with military biologists from Canada, Great Britain and Northern Ireland.

"Under this agreement, the three nations will work together to develop and produce a plague vaccine that will ultimately be licensed for human use," the Pentagon announcement said.

The United States and the United Kingdom have operated separate plague vaccine development programs for more than five years. In 2000, both countries and Canada signed a memorandum of understanding to share vaccine development information.

Last year, Congress passed Project Bioshield, with $6 billion in federal funding designed to spur private companies to develop vaccines and treatments for dangerous biological weapons. Experts and former government officials have said, however, that the program is falling short of its goals.

Officials have proposed a Project Bioshield II program to generate more industry initiatives, but most biological defense research is still in the hands of the federal government.

Defense officials plan to test the two plague vaccines currently in development and select one to receive additional attention and resources. The vaccine that is being researched in the United States was developed by the Army Medical Research Institute of Infectious Diseases. Researchers began testing the vaccine early this year at the University of Kentucky.

The British plague vaccine candidate is expected to begin testing in the United States in late 2005 under guidelines set out by the Food and Drug Administration. After results are in from those tests, officials will determine which vaccine to continue developing.

www.govexec.com...

This report is a few weeks old but it is intriguing. Although I often get the feeling there might be some critical chatter or CDC intel we're not being informed about, it is good to see this multi-national collaboration to avoid future worst case scenarios.

May 10, 2005 (CIDRAP News) – Federal health officials yesterday announced 12 grants and contracts worth $27 million to support development of drugs and vaccines for botulism, anthrax, and other diseases that terrorists might try to spread.

The grants are the first made by the National Institute of Allergy and Infectious Diseases (NIAID) under Project Bioshield, which Congress enacted last year to promote research on medical defenses against biological, chemical, radiological, and nuclear weapons.

The 10 Project Bioshield grant recipients, with the principal investigators and project goals, are as follows:

*Scripps Research Institute, La Jolla, Calif.; Kim Janda, PhD; drugs to reverse the paralysis caused by botulinum toxin
*Apath LLC, St. Louis; Paul Olivo, MD, PhD; new drugs for Ebola virus
*Veterans Affairs San Diego Healthcare System; Karl Hostetler, MD; a new antiviral drug for smallpox
*Arizona State University; Bertram Jacobs, PhD; ways to optimize the protective effect of smallpox vaccine when given after exposure to smallpox
*Novobiotic Pharmaceuticals LLC, Cambridge, Mass.; Losee Ling, PhD; new drugs to combat Bacillus anthracis, the anthrax agent
*Children's Hospital Oakland Research Institute, Oakland, Calif.; Donald Reason, PhD; development of antibodies for use in postexposure anthrax treatment
*Nanotherapeutics Inc., Alachua, Fla.; James Talton, PhD; single-dose inhalers to deliver two antibiotics for immediate postexposure protection against pneumonic plague and tularemia
*University of Chicago, Wei-Jen Tang, PhD; a drug to block the action of anthrax edema toxin, which causes human cells to swell
*MaxThera Inc., Reading, Mass.; Ania Knap, PhD; new antibacterial agents for a broad range of potential bioterror pathogens
*Veritas Inc., Rockville, Md.; George Oyler, MD, PHD; tests to screen tens of thousands of drugs to find those that inhibit the activity of botulinum toxin

The two companies receiving contracts are as follows:

*XOMA (US) LLC, Berkeley, Calif.; Marc Better, PhD; development of antibodies to protect against botulinum toxin type A
*DVC Dynport LLC, Frederick, Md.; Ian Henderson, PhD; production of a candidate vaccine against botulinum toxin type E

www.cidrap.umn.edu...

Good to see lots of research in the works to combat future bio/chem warfare. Never know what lies ahead, but from the list above you can see where the initial concerns may rest.